butoxamine has been researched along with xamoterol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Basu, S; Bhat, M; Lu, K; Mitra, R; Oberyszyn, T; Peters, S | 1 |
1 other study(ies) available for butoxamine and xamoterol
Article | Year |
---|---|
Suppression of beta 2 adrenergic receptor actions prevent UVB mediated cutaneous squamous cell tumorigenesis through inhibition of VEGF-A induced angiogenesis.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Animals; Butoxamine; Humans; Keratinocytes; Male; Mice, Inbred Strains; Neoplasms, Radiation-Induced; Neoplasms, Squamous Cell; Neovascularization, Pathologic; Receptors, Adrenergic, beta-2; Skin Neoplasms; Ultraviolet Rays; Vascular Endothelial Growth Factor A; Xamoterol | 2021 |